NO893894D0 - Non-a, nok-b hepatittvirus antigen-peptid. - Google Patents

Non-a, nok-b hepatittvirus antigen-peptid.

Info

Publication number
NO893894D0
NO893894D0 NO893894A NO893894A NO893894D0 NO 893894 D0 NO893894 D0 NO 893894D0 NO 893894 A NO893894 A NO 893894A NO 893894 A NO893894 A NO 893894A NO 893894 D0 NO893894 D0 NO 893894D0
Authority
NO
Norway
Prior art keywords
hepatitis
antigen
hepatitvirus
peptid
nok
Prior art date
Application number
NO893894A
Other languages
English (en)
Other versions
NO893894L (no
Inventor
Terukatsu Arima
Konosuke Fukai
Original Assignee
Univ Osaka Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1193233A external-priority patent/JP2696116B2/ja
Application filed by Univ Osaka Res Found filed Critical Univ Osaka Res Found
Publication of NO893894D0 publication Critical patent/NO893894D0/no
Publication of NO893894L publication Critical patent/NO893894L/no
Priority to NO950527A priority Critical patent/NO950527D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO89893894A 1988-09-30 1989-09-29 Non-a, nok-b hepatittvirus antigen-peptid. NO893894L (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO950527A NO950527D0 (no) 1988-09-30 1995-02-13 Analogifremgangsmåte ved fremstilling av non-A, non-B hepatittvirus-antigenpeptid

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP24717588 1988-09-30
JP5264289 1989-03-04
JP15325789 1989-06-14
JP1193233A JP2696116B2 (ja) 1988-09-30 1989-07-25 非ａ非ｂ肝炎患者の血清と抗原抗体反応するペプチド、及び該ペプチドをコードするｄｎａ

Publications (2)

Publication Number Publication Date
NO893894D0 true NO893894D0 (no) 1989-09-29
NO893894L NO893894L (no) 1990-04-02

Family

ID=27462798

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893894A NO893894L (no) 1988-09-30 1989-09-29 Non-a, nok-b hepatittvirus antigen-peptid.

Country Status (12)

Country Link
US (2) US5191064A (no)
EP (1) EP0363025B1 (no)
AT (1) ATE154391T1 (no)
AU (1) AU623433B2 (no)
CA (1) CA1341089C (no)
DE (1) DE68928119T2 (no)
DK (1) DK480889A (no)
FI (1) FI894580A (no)
HU (1) HUT58805A (no)
MY (1) MY104208A (no)
NO (1) NO893894L (no)
NZ (1) NZ230560A (no)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5698390A (en) 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
DE69033891T2 (de) * 1989-05-18 2002-08-29 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville NANBV-Diagnostika: Polynukleotide, geeignet für Reihenuntersuchungen auf Hepatitis C-Virus
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
LU87861A1 (fr) 1989-12-18 1991-10-08 Wellcome Found Agent viral
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
US5639594A (en) * 1990-02-16 1997-06-17 United Biomedical, Inc. Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5747239A (en) * 1990-02-16 1998-05-05 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5582968A (en) * 1990-02-16 1996-12-10 United Biomedical, Inc. Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
JPH0436185A (ja) * 1990-03-28 1992-02-06 Kyowa Hakko Kogyo Co Ltd 融合抗原ポリペプチド
ZA912040B (en) * 1990-03-30 1991-12-24 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus
US5712087A (en) * 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
JP3050395B2 (ja) * 1990-06-12 2000-06-12 国立感染症研究所長 Ｃ型肝炎ウイルス抗原ポリペプチド、その産生方法および抗体の検出方法
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
AU652941B2 (en) * 1990-06-25 1994-09-15 Research Foundation For Microbial Diseases Of Osaka University, The Non-A, Non-B hepatitis virus particles
EP0933426A1 (en) * 1990-06-25 1999-08-04 The Research Foundation for Microbial Diseases of Osaka University Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides
ES2069298T3 (es) * 1990-06-30 1995-05-01 Akzo Nobel Nv Secuencias no-a no-b.
JP3114731B2 (ja) * 1990-08-14 2000-12-04 国立感染症研究所長 Ｃ型肝炎ウイルス抗体検出用ペプチド抗原及びその使用方法
US7863008B2 (en) 1990-08-25 2011-01-04 Bioprocess Pty Ltd. Method for detecting NANBV associated seroconversion
CA2090335A1 (en) * 1990-08-25 1992-02-26 Suzanne Zebedee Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines
ES2070415T3 (es) * 1990-10-05 1995-06-01 Akzo Nobel Nv Peptidos inmunoquimicamente reactivos con anticuerpos dirigidos contra el virus de la hepatitis no-a, no-b.
DE59109221D1 (de) * 1990-11-03 2001-11-15 Dade Behring Marburg Gmbh HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
US5654179A (en) * 1990-11-14 1997-08-05 Hri Research, Inc. Nucleic acid preparation methods
AU640569B2 (en) 1991-03-26 1993-08-26 Dade International Inc. Assay for non-a non-b hepatitis
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
AU648912B2 (en) * 1991-06-13 1994-05-05 Dade International Inc. Immunoassay for non-A non-B hepatitis
DE4209215A1 (de) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
ZA927837B (en) * 1991-10-15 1994-03-11 Akzo Nv Monoclonal antibodiesto hepatitis C virus
US5437974A (en) * 1992-02-04 1995-08-01 Dade International Inc DNA sequence and encoded polypeptide useful in the diagnosis of hepatitis disease
US6297048B1 (en) * 1992-02-04 2001-10-02 Chiron Corporation Hepatitis therapeutics
US5859230A (en) * 1992-07-30 1999-01-12 Genelabs Technologies, Inc. Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
WO1994004922A1 (en) * 1992-08-21 1994-03-03 Abbott Laboratories Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections
US5874563A (en) * 1994-05-20 1999-02-23 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
US5824507A (en) * 1994-05-20 1998-10-20 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
US7235394B1 (en) 1995-08-29 2007-06-26 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US7049428B1 (en) * 1998-03-04 2006-05-23 Washington University HCV variants
AU4825699A (en) * 1998-06-19 2000-01-05 Genzyme Corporation Identification and use of differentially expressed genes and polynucleotide sequences
US7666661B2 (en) 2001-08-27 2010-02-23 Platypus Technologies, Llc Substrates, devices, and methods for quantitative liquid crystal assays
FR2839555B1 (fr) 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
AU2003299522B2 (en) * 2002-05-22 2008-03-06 Platypus Technologies, Llc Substrates, devices, and methods for cellular assays
CA2533659A1 (en) 2003-07-25 2005-03-10 Platypus Technologies, Llc Liquid crystal based analyte detection
AU2004290432B2 (en) 2003-11-10 2008-11-20 Platypus Technologies, Llc Substrates, devices, and methods for cellular assays
WO2007025129A2 (en) 2005-08-25 2007-03-01 Platypus Technologies, Llc. Compositions and liquid crystals
US7842499B2 (en) * 2006-08-07 2010-11-30 Platypus Technologies, Llc Substrates, devices, and methods for cellular assays
EP2193365A4 (en) 2007-08-20 2015-05-13 Platypus Technologies Llc IMPROVED DEVICES FOR CELL TESTS
EP2344879A4 (en) * 2008-09-15 2013-03-20 Platypus Technologies Llc DETECTION OF STEAM PHASE COMPOUNDS BY CHANGING THE PHYSICAL PROPERTIES OF A LIQUID CRYSTAL

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356164A (en) * 1979-05-21 1982-10-26 Govt. of the U.S., as represented by the Secretary, Dept. of Health & Human Services Detection of non-A, non-B hepatitis associated antigen
US4291020A (en) * 1980-05-16 1981-09-22 The United States Of America As Represented By The Secretary Of Health & Human Services Inactivation of non-A, non-B hepatitis agent
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
EP0071640B1 (en) * 1981-02-11 1986-06-04 Connaught Laboratories Incorporated Non-a, non-b hepatitis virus
US4542016A (en) * 1981-03-27 1985-09-17 Institut Merieux Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use
JPS57198867A (en) * 1981-06-02 1982-12-06 Eisai Co Ltd Non-a, non-b hepatitis related antigen and diagnostic therefor
JPS58753A (ja) * 1981-06-25 1983-01-05 Eisai Co Ltd 非ａ非ｂ型肝炎関連抗体および検出試薬
US4438098A (en) * 1982-01-27 1984-03-20 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Heat treatment of a non-A, non-B hepatitis agent to prepare a vaccine
JPS58183629A (ja) * 1982-04-21 1983-10-26 Eisai Co Ltd 非ａ非ｂ型肝炎関連モノクロナ−ル抗体および診断薬
EP0093438B1 (en) * 1982-05-05 1988-07-20 Louisiana State University and Agricultural and Mechanical College Non-a, non-b hepatitis antigen
US4702909A (en) * 1982-05-05 1987-10-27 Louisiana State University A & M Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent
JPS59501774A (ja) * 1982-09-16 1984-10-25 ザ　ゼネラル　ホスピタル　コ−ポレ−シヨン 非ａ型、非ｂ型肝炎ウイルス、同定方法、精製、特徴付け、診断及び免疫化
CA1207662A (en) * 1982-12-02 1986-07-15 Ricardo H. Landaburu Hepatitis b and non-a-non-b-safe biological products
DE3316464A1 (de) * 1983-05-05 1984-11-08 Heinrich Prof Dr Med Liehr Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
JPS60176600A (ja) * 1984-02-24 1985-09-10 Fujimoto Rinshiyou Kensa Kenkyusho:Kk グアナ−ゼ活性測定方法
ZA8410091B (en) * 1984-03-02 1985-08-28 Warner Lambert Co Detection of non-a,non-b hepatitis
JPS6125484A (ja) * 1984-07-16 1986-02-04 Isao Ono 抗体を産生する細胞株
JPS6156196A (ja) * 1984-07-16 1986-03-20 Isao Ono モノクロ−ナル抗体
US4707439A (en) * 1984-10-26 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH
JPS61176856A (ja) * 1985-02-01 1986-08-08 Mitsubishi Chem Ind Ltd 非ａ非ｂ型肝炎抗原
US4673634A (en) * 1985-03-08 1987-06-16 The United States Of America As Represented By The Department Of Health And Human Services Purified antigen from non-A, non-B hepatitis causing factor
JPS62181798A (ja) * 1986-02-06 1987-08-10 Isao Ono モノクロ−ナル抗体
JPS6391328A (ja) * 1986-10-07 1988-04-22 Mitsubishi Kasei Corp 非ａ非ｂ型肝炎抗原
DE3744242A1 (de) * 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
DE3886363T3 (de) * 1987-11-18 2004-09-09 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville NANBV-Diagnostika
EP0423239A4 (en) * 1988-07-06 1992-05-20 Genelabs Incorporated Post-transfusion, non-a, non-b hepatitis virus and antigens
JPH02167081A (ja) * 1988-12-21 1990-06-27 Tetsuo Nakamura 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV

Also Published As

Publication number Publication date
CA1341089C (en) 2000-08-22
US5191064A (en) 1993-03-02
EP0363025B1 (en) 1997-06-11
ATE154391T1 (de) 1997-06-15
FI894580A0 (fi) 1989-09-27
EP0363025A2 (en) 1990-04-11
DE68928119D1 (de) 1997-07-17
DK480889D0 (da) 1989-09-29
MY104208A (en) 1994-02-28
DE68928119T2 (de) 1998-01-08
AU4179989A (en) 1990-04-05
NZ230560A (en) 1992-05-26
US5298394A (en) 1994-03-29
AU623433B2 (en) 1992-05-14
NO893894L (no) 1990-04-02
HUT58805A (en) 1992-03-30
FI894580A (fi) 1990-03-31
EP0363025A3 (en) 1990-04-25
DK480889A (da) 1990-04-02

Similar Documents

Publication Publication Date Title
NO893894D0 (no) Non-a, nok-b hepatittvirus antigen-peptid.
DE68903165D1 (de) Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.
DK0992580T3 (da) Epitoper på human T-celler, som er immundominante for hepatitis C-virus
ES2152922T3 (es) Epitopos del virus de la hepatitis c.
DE69131149D1 (de) Synthetische Peptide, spezifisch zum Nachweis von gegen HCV gerichteten Antikörpern zur Diagnose der HCV-Infektion und zum Vorkommen davon als Impfstoffe
NO905438L (no) Virusmiddel.
ATE170220T1 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
DE69111801D1 (de) Vakzin gegen hepatitis b.
ES2170152T3 (es) Virus de la hepatitis g y clon molecular del mismo.
Tabor et al. REMOVAL OF HEPATITIS-B-VIRUS INFECTIVITY FROM FACTOR-IX COMPLEX BY HEPATITIS-B IMMUNE-GLOBULIN: Experiments in Chimpanzees
DK245287A (da) Peptider relateret til htlv-iii virus, antistoffer mod disse peptider, vacciner til aktiv og passiv immunisering mod aids-virus og fremgangsmaade og udstyr til serologisk paavisning af aids virus
EP1572721A4 (en) PREVENTING AND TREATING VCH INFECTION USING ANTIBODIES AGAINST CONFORMATIONAL AND LINEAR EPITOPES
ATE109158T1 (de) Rubella-e1 und c peptide.
DE69523055D1 (de) T-zellen stimulierendes protein von pestivirus
CA2080213A1 (en) Diagnostic reagent for hepatitis c
EP0250128A3 (en) Novel virus isolated from patients with aids
SE9002671D0 (sv) Nya peptider, diagnostiska antigener, anvaendning daerav och vacciner
TH7280A (th) เพปไทด์ที่เป็นแอนติเจนของไวรัสโรคตับอักเสบชนิดnon-A,non-B
IT1270941B (it) Peptidi di hcv e loro usi.
TH7280EX (th) เพปไทด์ที่เป็นแอนติเจนของไวรัสโรคตับอักเสบชนิดnon-A,non-B
IT1273996B (it) Uso di anticorpi che riconoscono la proteina 90k nella diagnostica clinica e nel monitoraggio dei pazienti affetti da epatite virale
TH9844EX (th) เพพไทด์ที่สัมพันธุ์ hiv
TH9844A (th) เพพไทด์ที่สัมพันธุ์ hiv
RU93012074A (ru) Набор для диагностики гриппа свиней